医学
瓣膜性心脏病
疾病管理
梅德林
疾病
重症监护医学
内科学
心脏病学
帕金森病
政治学
法学
作者
Alec Vahanian,Friedhelm Beyersdorf,Fabien Praz,Milan Milojevic,Stephan Baldus,Johann Bauersachs,Davide Capodanno,Lenard Conradi,Michele De Bonis,Ruggero De Paulis,Victoria Delgado,Nick Freemantle,Kristina Haugaa Haugaa,Anders Jeppsson,Peter Jüni,Luc Piérard,Bernard Prendergast,Rafael Sádaba,Christophe Tribouilloy,Wojciech Wojakowski
出处
期刊:Eurointervention
[European Association of Percutaneous Cardiovascular Interventions]
日期:2022-02-01
卷期号:17 (14): e1126-e1196
被引量:279
标识
DOI:10.4244/eij-e-21-00009
摘要
The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their dating.The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of health care or therapeutic strategies.Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgment as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies.However, the ESC Guidelines do not override in any way whatsoever the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and the patient's caregiver where appropriate and/or necessary.Nor do the ESC Guidelines exempt health professionals from taking careful and full consideration of the relevant official updated recommendations or guidelines issued by the competent public health authorities in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations.It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.
科研通智能强力驱动
Strongly Powered by AbleSci AI